Solvotrin chief executive Pat O’Flynn (centre) with chief operating officer  Ronan McClafferty (left) and  George Walsh, chief financial officer

Solvotrin Therapeutics, a Cork-based supplements group, has raised €6.7 million in funding from new and existing investors as it looks to expand in Ch(...)

Solvotrin Therapeutics   executive chairman Peter Caldini and chief executive Pat O’Flynn.

Cork-based medicine development company Solvotrin Therapeutics has agreed a 20-year exclusive licensing and distribution deal for China with leading h(...)

Solvotrin CEO Pat O’Flynn flanked by Prof John Gilmer of Trinity College Dublin and Prof Mark Ledwidge of UCD. Their product,  Active Iron, launched last year and was quickly snapped up by Boots

A groundbreaking iron product from Cork-based life sciences start-up Solvotrin Therapeutics looks set to disrupt the €10 billion global market for ora(...)